Get startedLog in
    Picture of Syros Pharmaceuticals logo

    SYRS — Syros Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Syros Highlights Anticipated 2024 Milestones To Deliver On The Value Of Tamibarotene

    Picture of Syros Pharmaceuticals logoSyros Pharmaceuticals
    08/01/2024 13:21
    Jan 8 (Reuters) - Syros Pharmaceuticals Inc  SYRS.O :
    * SYROS HIGHLIGHTS ANTICIPATED 2024 MILESTONES TO DELIVER ON
THE
VALUE OF TAMIBAROTENE
    * SYROS PHARMACEUTICALS: STRENGTHENED BALANCE SHEET WITH
GROSS
PROCEEDS OF ABOUT $45.0 MILLION FROM RECENT EQUITY FINANCING
    * SYROS PHARMACEUTICALS INC: EXTENDING CASH RUNWAY INTO 2Q
2025

Source text for Eikon:  ID:nBw88lv3wa 
Further company coverage:  SYRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Syros Pharmaceuticals

    See all news